References
- Hume M, Glenn W WL, Grillo T. Behavior in the circulation of the radioactive pulmonary embolus and its application to the study of fibrinolytic enzymes. Ann Surg 1960; 151: 507–516
- Egeblad K, Bertelsen S. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin. Acta Chir Scand 1969; 135: 486–490
- Cade J F, Hirsh J, Regoeczi E. Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens. J Clin Invest 1974; 54: 782–791
- Hisano S, Sueishi K, Ishii Y. Immunohistochemical and histochemical investigations on in viva thrombolysis with urokinase in rabbits. Thromb Haemost 1979; 41: 796–803
- Korninger C, Matsuo O, Suy R. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. J Clin Invest 1982; 69: 573–580
- Dupe R J, Green J, Smith R AG. Acylated derivatives of streptokinase-plasminogen activator complex as thrombolytic agents in a dog model of aged venous thrombosis. Thromb Haemost 1985; 53: 56–59
- Sherry S, Titchener A, Gottesman L. The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators. J Clin Invest 1954; 33: 1303–1313
- Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237–246
- Snedecor G W, Cochran W G. Statistical Methods ed 7. The Iowa State University Press, Ames, IA 1980; 144–145
- Vairel E G, Bouty-Boye H, Toulemonde F. Heparin and low molecular weight fraction enhances thrombolysis and by this way exercises a protective effect against thrombosis. Thromb Res 1983; 30: 219–224
- Vinazzer H, Stemberger A, Haas S. Influence of heparin of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis. Thromb Res 1982; 27: 341–352
- Fareed J, Walenga J M, Hoppensteadt D A. Studies on the profibrinolytic actions of heparin and its fractions. Semin Thromb Hemost 1985; 11: 199–207
- Markwardt F, Klocking H P. Heparin-induced release of plasminogen activator. Haemostasis 1977; 6: 370–374
- Paques E P, Stohr H A, Heimburger N. Study on the mechanism of action of heparin and related substances on the fibrinolytic system: Relationship between plasminogen activators and heparin. Thromb Res 1986; 42: 797–807
- Rosenberg R D. The effect of heparin on factor XIa and plasmin. Thromb Diathes Haemorrh 1974; 33: 51–62
- Telesforo P, Semeraro N, Verstraete M. The inhibition of plasmin by antithrombin III-heparin complex in vitro in human plasma and during streptokinase therapy in man. Thromb Res 1975; 7: 669–676
- Tsapogas M J, Flute P T. Experimental thrombolysis with streptokinase and urokinase. Br Med Bull 1964; 20: 223–227
- Cade J, Hirsh J, Regoeczi E. Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism. Blood 1975; 45: 563–568